Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology|November 6, 2004
Housekeeping genes as internal standards in cancer researchNico Janssens, Michel Janicot, Tim Perera, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 24, 2004
Alteration of frizzled expression in renal cell carcinomaNico Janssens, Luc Andries, Michel Janicot, et al.
JCI Insight|August 21, 2020
Phenotypic heterogeneity of neurofibromatosis type 1 in a large international registryMika M Tabata, Shufeng Li, Pamela Knight, et al.
Plos One|June 24, 2017
Characterization and utilization of an international neurofibromatosis web-based, patient-entered registry: An observational studyMindell Seidlin, Robert Holzman, Pamela Knight, et al.
BMC Cancer|June 24, 2009
KIF11 inhibition for glioblastoma treatment: reason to hope or a struggle with the brain?Silvia Valensin, Chiara Ghiron, Claudia Lamanna, et al.
Chemmedchem|May 13, 2009
How to achieve confidence in drug discovery and development: managing risk (from a reductionist to a holistic approach)Annette Bakker, Andrea Caricasole, Giovanni Gaviraghi, et al.
British Journal of Cancer|April 27, 2018
Cutaneous neurofibromas in the genomics era: current understanding and open questionsRobert J Allaway, Sara J C Gosline, Salvatore La Rosa, et al.
Cancer Biology & Therapy|February 16, 2011
β-catenin and Gli1 are prognostic markers in glioblastomaMarco Rossi, Letizia Magnoni, Clelia Miracco, et al.
Bioscience Reports|April 30, 2010
Pancreatic cancer spheres are more than just aggregates of stem marker-positive cellsMargherita Gaviraghi, Patrizia Tunici, Silvia Valensin, et al.
Drug Discovery Today|June 16, 2026
Estimating the global inventory of deprioritized clinical-stage drug development programs: Toward a market for shelved assetsAnnette Bakker, Tanisha Carino, Joonhyuk Cho, et al.
Pageof 4